BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 31655358)

  • 1. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
    Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
    Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
    Dingemans AC; Hendriks LEL; Berghmans T; Levy A; Hasan B; Faivre-Finn C; Giaj-Levra M; Giaj-Levra N; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Smit EF; Van Schil P; Postmus PE; Ramella S; Lievens Y; Gaga M; Peled N; Scagliotti GV; Senan S; Paz-Ares L; Guckenberger M; McDonald F; Ekman S; Cufer T; Gietema H; Infante M; Dziadziuszko R; Peters S; Porta RR; Vansteenkiste J; Dooms C; de Ruysscher D; Besse B; Novello S
    J Thorac Oncol; 2019 Dec; 14(12):2109-2119. PubMed ID: 31398540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
    Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;
    Eur J Cancer; 2019 Nov; 122():109-114. PubMed ID: 31671363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
    Parikh RB; Cronin AM; Kozono DE; Oxnard GR; Mak RH; Jackman DM; Lo PC; Baldini EH; Johnson BE; Chen AB
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):880-7. PubMed ID: 24867533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
    Giaj-Levra N; Giaj-Levra M; Durieux V; Novello S; Besse B; Hasan B; Hendriks LE; Levy A; Dingemans AC; Berghmans T;
    J Thorac Oncol; 2019 Dec; 14(12):2053-2061. PubMed ID: 31195177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.
    Kroese TE; van Hillegersberg R; Schoppmann S; Deseyne PRAJ; Nafteux P; Obermannova R; Nordsmark M; Pfeiffer P; Hawkins MA; Smyth E; Markar S; Hanna GB; Cheong E; Chaudry A; Elme A; Adenis A; Piessen G; Gani C; Bruns CJ; Moehler M; Liakakos T; Reynolds J; Morganti A; Rosati R; Castoro C; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; Jeene P; van Sandick JW; Muijs C; Slingerland M; Nieuwenhuijzen G; Wijnhoven B; Beerepoot LV; Kolodziejczyk P; Polkowski WP; Alsina M; Pera M; Kanonnikoff TF; Nilsson M; Guckenberger M; Monig S; Wagner D; Wyrwicz L; Berbee M; Gockel I; Lordick F; Griffiths EA; Verheij M; van Rossum PSN; van Laarhoven HWM;
    Eur J Cancer; 2022 Mar; 164():18-29. PubMed ID: 35134666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases.
    Ponce S; Bruna J; Juan O; López R; Navarro A; Ortega AL; Puente J; Verger E; Bartolomé A; Nadal E
    Crit Rev Oncol Hematol; 2019 Jun; 138():190-206. PubMed ID: 31092376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Juan O; Popat S
    Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
    Kudelin N; Bölükbas S; Schirren J
    Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome for patients with primary NSCLC and synchronous solitary metastasis.
    Xu Q; Wang Y; Liu H; Meng S; Zhou S; Xu J; Schmid-Bindert G; Zhou C
    Clin Transl Oncol; 2013 Oct; 15(10):802-9. PubMed ID: 23430537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
    Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Tanaka F
    Clin Lung Cancer; 2012 May; 13(3):220-4. PubMed ID: 22138036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy for oligometastatic non-small cell lung cancer patients].
    Levy A; Roux C; Mercier O; Issard J; Botticella A; Barlesi F; Le Péchoux C
    Cancer Radiother; 2021 Oct; 25(6-7):517-522. PubMed ID: 34175225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy.
    Miyawaki T; Wakuda K; Kenmotsu H; Miyawaki E; Mamesaya N; Kobayashi H; Omori S; Ono A; Naito T; Murakami H; Notsu A; Mori K; Harada H; Endo M; Ohde Y; Takahashi K; Takahashi T
    Cancer Sci; 2021 Jan; 112(1):359-368. PubMed ID: 33098119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of non-small cell lung cancer with oligometastasis.
    Villaruz LC; Kubicek GJ; Socinski MA
    Curr Oncol Rep; 2012 Aug; 14(4):333-41. PubMed ID: 22535505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery.
    Congedo MT; Nachira D; Bertolaccini L; Chiappetta M; Zanfrini E; Meacci E; Vita ML; Lococo F; D'Argento E; Spaggiari L; Margaritora S
    J Surg Oncol; 2022 Mar; 125(4):782-789. PubMed ID: 34918785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
    Johnson KK; Rosen JE; Salazar MC; Boffa DJ
    Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
    Leduc C; Antoni D; Quoix É; Noël G
    Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management.
    Loi M; Mazzella A; Mansuet-Lupo A; Bobbio A; Canny E; Magdeleinat P; Régnard JF; Damotte D; Trédaniel J; Alifano M
    Ann Thorac Surg; 2019 Apr; 107(4):1053-1059. PubMed ID: 30476480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.